469 related articles for article (PubMed ID: 17587760)
1. Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia.
Davis HR; Veltri EP
J Atheroscler Thromb; 2007 Jun; 14(3):99-108. PubMed ID: 17587760
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of intestinal cholesterol absorption by ezetimibe is a novel therapeutic target for fatty liver.
Yamagishi S; Nakamura K; Matsui T; Sato T; Takeuchi M
Med Hypotheses; 2006; 66(4):844-6. PubMed ID: 16188393
[TBL] [Abstract][Full Text] [Related]
3. Ezetimibe: a selective cholesterol absorption inhibitor.
Nutescu EA; Shapiro NL
Pharmacotherapy; 2003 Nov; 23(11):1463-74. PubMed ID: 14620392
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of ezetimibe is not related to NPC1L1 gene polymorphisms in a pilot study of Chilean hypercholesterolemic subjects.
Zambrano T; Saavedra N; Lanas F; Caamaño J; Salazar LA
Mol Diagn Ther; 2015 Feb; 19(1):45-52. PubMed ID: 25589339
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol homeostasis by the intestine: lessons from Niemann-Pick C1 Like 1 [NPC1L1).
Davis HR; Basso F; Hoos LM; Tetzloff G; Lally SM; Altmann SW
Atheroscler Suppl; 2008 Sep; 9(2):77-81. PubMed ID: 18585981
[TBL] [Abstract][Full Text] [Related]
6. Intestinal sterol transporters and cholesterol absorption inhibition.
Davis HR; Tershakovec AM; Tomassini JE; Musliner T
Curr Opin Lipidol; 2011 Dec; 22(6):467-78. PubMed ID: 22101558
[TBL] [Abstract][Full Text] [Related]
7. Ezetimibe: rationale and role in the management of hypercholesterolemia.
Yatskar L; Fisher EA; Schwartzbard A
Clin Cardiol; 2006 Feb; 29(2):52-5. PubMed ID: 16506638
[TBL] [Abstract][Full Text] [Related]
8. [Cholesterol homeostasis and enterohepatic connection: new insights in cholesterol absorption].
Klop B; Elte JW; Cabezas MC
Ned Tijdschr Geneeskd; 2011; 155():A2503. PubMed ID: 21262010
[TBL] [Abstract][Full Text] [Related]
9. [An inhibitor of intestinal cholesterol transporter].
Sano M
Nihon Rinsho; 2013 Sep; 71(9):1661-6. PubMed ID: 24205731
[TBL] [Abstract][Full Text] [Related]
10. Effects of ezetimibe added to statin therapy on markers of cholesterol absorption and synthesis and LDL-C lowering in hyperlipidemic patients.
Thongtang N; Lin J; Schaefer EJ; Lowe RS; Tomassini JE; Shah AK; Tershakovec AM
Atherosclerosis; 2012 Dec; 225(2):388-96. PubMed ID: 23040830
[TBL] [Abstract][Full Text] [Related]
11. Ezetimibe for hypercholesterolemia.
Morris S; Tiller R
Am Fam Physician; 2003 Oct; 68(8):1595-6. PubMed ID: 14596448
[TBL] [Abstract][Full Text] [Related]
12. Ezetimibe: cholesterol lowering and beyond.
Bays HE; Neff D; Tomassini JE; Tershakovec AM
Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
[TBL] [Abstract][Full Text] [Related]
13. Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment.
Simon JS; Karnoub MC; Devlin DJ; Arreaza MG; Qiu P; Monks SA; Severino ME; Deutsch P; Palmisano J; Sachs AB; Bayne ML; Plump AS; Schadt EE
Genomics; 2005 Dec; 86(6):648-56. PubMed ID: 16297596
[TBL] [Abstract][Full Text] [Related]
14. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
15. Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels.
Xie P; Zhu H; Jia L; Ma Y; Tang W; Wang Y; Xue B; Shi H; Yu L
Atherosclerosis; 2014 Dec; 237(2):609-17. PubMed ID: 25463095
[TBL] [Abstract][Full Text] [Related]
16. Niemann-Pick C1-Like 1 (NPC1L1) Inhibition and Cardiovascular Diseases.
Pirillo A; Catapano AL; Norata GD
Curr Med Chem; 2016; 23(10):983-99. PubMed ID: 26923679
[TBL] [Abstract][Full Text] [Related]
17. Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport.
Jia L; Betters JL; Yu L
Annu Rev Physiol; 2011; 73():239-59. PubMed ID: 20809793
[TBL] [Abstract][Full Text] [Related]
18. [Ezetimibe: from pharmacology to clinical trials].
Tellier P
Ann Endocrinol (Paris); 2003 Dec; 64(6):442-7. PubMed ID: 15067249
[TBL] [Abstract][Full Text] [Related]
19. Ezetimibe--a new approach in hypercholesterolemia management.
Suchy D; Łabuzek K; Stadnicki A; Okopień B
Pharmacol Rep; 2011; 63(6):1335-48. PubMed ID: 22358082
[TBL] [Abstract][Full Text] [Related]
20. Where does the interplay between cholesterol absorption and synthesis in the context of statin and/or ezetimibe treatment stand today?
Descamps OS; De Sutter J; Guillaume M; Missault L
Atherosclerosis; 2011 Aug; 217(2):308-21. PubMed ID: 21762916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
